NEW YORK (GenomeWeb News) — Nanogen yesterday said fourth-quarter revenues increased 180 percent as R&D spending remained flat and net losses decreased 84 percent.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $8.7 million from $3.1 million year over year.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.